Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
Rhea-AI Summary
Applied DNA Sciences, Inc. (NASDAQ:APDN) has announced the release of its third quarter fiscal 2024 financial results on Thursday, August 8, 2024, after market close. The company will host a conference call for analysts and investors at 4:30 p.m. ET on the same day to discuss the financial results and recent accomplishments. Domestic callers can dial toll-free at 844-887-9402, while international callers can use 412-317-6798. A live webcast will be available, and a slide presentation will be embedded in the webcast. A telephonic replay of the conference call will be accessible until August 15, with replay access codes provided for different regions.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, APDN declined 6.10%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
STONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its third quarter fiscal 2024 financial results after market close on Thursday, August 8, 2024. In conjunction with this announcement, Applied DNA management will host a conference call for analysts and members of the investment community starting at 4:30 p.m. ET the same day. On this call, management will discuss the Company's financial results and recent accomplishments.
Date & Time: Thursday, August 8 @ 4:30 p.m. ET
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=WL2w2oZh
A telephonic replay of the conference call will be available until August 15 following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 9045385
Replay for international callers: 412-317-0088, replay access code 9045385
Replay for Canadian callers (toll free): 855-669-9658, replace access code 9045385
An accompanying slide presentation will be embedded in the webcast (live and replay) and can be accessed in the ‘Company Events' section under the ‘News & Events' tab of the Applied DNA investor relations website at https://investors.adnas.com/
The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, through our recent acquisition of Spindle Biotech, Inc. ("Spindle"), the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
X: @APDN
###
SOURCE: Applied DNA Sciences
View the original press release on accesswire.com
FAQ
When will Applied DNA Sciences (APDN) release its Q3 2024 financial results?
What time is Applied DNA's (APDN) Q3 2024 earnings call scheduled for?
How can investors access Applied DNA's (APDN) Q3 2024 earnings call?
Until what date will the replay of Applied DNA's (APDN) Q3 2024 earnings call be available?
